https://stock.noler.com/us/stock/finch-therapeutics-group-inc https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accounts-payable https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accounts-receivable https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/accumulated-depreciation https://stock.noler.com/us/stock/finch-therapeutics-group-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/finch-therapeutics-group-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/finch-therapeutics-group-inc/asset-impairment-charges https://stock.noler.com/us/stock/finch-therapeutics-group-inc/basic-shares https://stock.noler.com/us/stock/finch-therapeutics-group-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-expenditures https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/finch-therapeutics-group-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cash-and-equivalents https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cash-flow-breakdown https://stock.noler.com/us/stock/finch-therapeutics-group-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/finch-therapeutics-group-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/finch-therapeutics-group-inc/common-stock-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/finch-therapeutics-group-inc/contract-liability https://stock.noler.com/us/stock/finch-therapeutics-group-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cost-maintenance https://stock.noler.com/us/stock/finch-therapeutics-group-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/finch-therapeutics-group-inc/current-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/current-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/finch-therapeutics-group-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/finch-therapeutics-group-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/finch-therapeutics-group-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/finch-therapeutics-group-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-offering-costs https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-liabilities-goodwill-and-intangible-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/finch-therapeutics-group-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/finch-therapeutics-group-inc/depreciation https://stock.noler.com/us/stock/finch-therapeutics-group-inc/depreciation-and-amortization https://stock.noler.com/us/stock/finch-therapeutics-group-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/diluted-shares https://stock.noler.com/us/stock/finch-therapeutics-group-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/finch-therapeutics-group-inc/due-from-related-parties-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/due-to-related-parties-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/finch-therapeutics-group-inc/effective-tax-rate https://stock.noler.com/us/stock/finch-therapeutics-group-inc/eps https://stock.noler.com/us/stock/finch-therapeutics-group-inc/eps-basic https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-liability-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/finch-therapeutics-group-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/financing-cash-flow https://stock.noler.com/us/stock/finch-therapeutics-group-inc/form-d-other https://stock.noler.com/us/stock/finch-therapeutics-group-inc/form-d-stocks https://stock.noler.com/us/stock/finch-therapeutics-group-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/finch-therapeutics-group-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/finch-therapeutics-group-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/finch-therapeutics-group-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/finch-therapeutics-group-inc/general-and-administrative-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/goodwill https://stock.noler.com/us/stock/finch-therapeutics-group-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/finch-therapeutics-group-inc/goodwill-change https://stock.noler.com/us/stock/finch-therapeutics-group-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/finch-therapeutics-group-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/finch-therapeutics-group-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/finch-therapeutics-group-inc/income-tax https://stock.noler.com/us/stock/finch-therapeutics-group-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/finch-therapeutics-group-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/insider-transactions-preferred https://stock.noler.com/us/stock/finch-therapeutics-group-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/finch-therapeutics-group-inc/interest-paid-net https://stock.noler.com/us/stock/finch-therapeutics-group-inc/investing-cash-flow https://stock.noler.com/us/stock/finch-therapeutics-group-inc/investment-income-net https://stock.noler.com/us/stock/finch-therapeutics-group-inc/lease-cost https://stock.noler.com/us/stock/finch-therapeutics-group-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/finch-therapeutics-group-inc/long-term-debt https://stock.noler.com/us/stock/finch-therapeutics-group-inc/net-change-in-cash https://stock.noler.com/us/stock/finch-therapeutics-group-inc/net-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/finch-therapeutics-group-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/finch-therapeutics-group-inc/number-of-operating-segments https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-cash-flow https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-expenses https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-cost https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-liability-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-payments-use https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/finch-therapeutics-group-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-noncurrent-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/finch-therapeutics-group-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/finch-therapeutics-group-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/finch-therapeutics-group-inc/preferred-shares-facts https://stock.noler.com/us/stock/finch-therapeutics-group-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/finch-therapeutics-group-inc/preferred-stock-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/finch-therapeutics-group-inc/prepaid-insurance https://stock.noler.com/us/stock/finch-therapeutics-group-inc/pretax-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/finch-therapeutics-group-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/finch-therapeutics-group-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/finch-therapeutics-group-inc/profit-loss https://stock.noler.com/us/stock/finch-therapeutics-group-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/finch-therapeutics-group-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/finch-therapeutics-group-inc/property-plant-equipment https://stock.noler.com/us/stock/finch-therapeutics-group-inc/public-float https://stock.noler.com/us/stock/finch-therapeutics-group-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/finch-therapeutics-group-inc/research-and-development https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restricted-cash https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restructuring-charges https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restructuring-costs https://stock.noler.com/us/stock/finch-therapeutics-group-inc/restructuring-reserve https://stock.noler.com/us/stock/finch-therapeutics-group-inc/retained-earnings https://stock.noler.com/us/stock/finch-therapeutics-group-inc/revenue https://stock.noler.com/us/stock/finch-therapeutics-group-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/finch-therapeutics-group-inc/shareholders-equity https://stock.noler.com/us/stock/finch-therapeutics-group-inc/shares-authorized https://stock.noler.com/us/stock/finch-therapeutics-group-inc/shares-issued https://stock.noler.com/us/stock/finch-therapeutics-group-inc/short-term-lease-cost https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-award-shares-purchased-for-award https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-based-compensation https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-issued-shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/finch-therapeutics-group-inc/sublease-income https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/finch-therapeutics-group-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/finch-therapeutics-group-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/finch-therapeutics-group-inc/total-assets https://stock.noler.com/us/stock/finch-therapeutics-group-inc/total-liabilities https://stock.noler.com/us/stock/finch-therapeutics-group-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/finch-therapeutics-group-inc/total-long-term-debt https://stock.noler.com/us/stock/finch-therapeutics-group-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/finch-therapeutics-group-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/finch-therapeutics-group-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/finch-therapeutics-group-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/finch-therapeutics-group-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/finch-therapeutics-group-inc/variable-lease-cost https://stock.noler.com/us/stock/finch-therapeutics-group-inc/weighted-average-number-of-share-outstanding-basic-and-diluted